P00268 (RUBR_CLOPA) Clostridium pasteurianum
Rubredoxin UniProtKBInterProInteractive Modelling
54 aa; Sequence (Fasta) ;
1 identical sequence: Clostridium pasteurianum DSM 525 = ATCC 6013: A0A0H3JBJ6
It is possible new templates exist for this target since these models were created.
Available Structures
45 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal Structure of CC Chemokine Receptor 5 (CCR5) in complex with high potency HIV entry inhibito… |
Heteromer P13501; P51681; | 100 | 1×ZN; 6×OLC; 2×OLA; | |||
| Structure of apelin receptor in complex with agonist peptide |
Heteromer P35414; | 100 | 1×ZN; 1×OLC; | |||
| Crystal structure of full length human GLP1 receptor in complex with Fab fragment (Fab7F38) |
Heteromer P43220; | 100 | 1×NAG; 1×ZN; 1×97Y; | |||
| Apelin receptor in complex with single domain antibody |
Heteromer P35414; | 100 | 1×ZN; | |||
| XFEL crystal structure of human melatonin receptor MT2 in complex with 2-phenylmelatonin |
Heteromer P0ABE7; P49286; | 100 | 2×JEY; 1×ZN; 1×OLC; | |||
| CLOSTRIDIUM PASTEURIANUM RUBREDOXIN C42S MUTANT | homo-3-mer | 98.15 | 3×FE; | |||
| RUBREDOXIN (OXIDIZED, FE(III)) AT 1.1 ANGSTROMS RESOLUTION | homo-3-mer | 100 | 3×FE; | |||
| RUBREDOXIN (ZN-SUBSTITUTED) AT 1.2 ANGSTROMS RESOLUTION | homo-3-mer | 100 | 3×ZN; | |||
| RUBREDOXIN V44A CP | homo-3-mer | 98.11 | 3×FE; | |||
| COMBINED CRYSTALLOGRAPHIC REFINEMENT AND ENERGY MINIMIZATION OF RUBREDOXIN AT 1.2 ANGSTROM RESOLUTI… | monomer | 94.44 | 1×FE; | |||
| CRYSTALLOGRAPHIC REFINEMENT OF RUBREDOXIN AT 1.2 ANGSTROMS RESOLUTION | monomer | 94.44 | 1×FE; | |||
| Crystal Structure of Cp Rd L41A mutant in oxidized state | monomer | 98.15 | 1×SO4; 1×FE; | |||
| Crystal Structure of Cp Rd L41A mutant in reduced state 2 (soaked) | monomer | 98.15 | 1×FE2; | |||
| Crystal Structure of Cp Rd L41A mutant in reduced state 1 (drop-reduced) | monomer | 98.15 | 1×FE2; | |||
| CLOSTRIDIUM PASTEURIANUM RUBREDOXIN G10A MUTANT | monomer | 98.15 | 1×FE; | |||
| Crystal Structure of V44A, G45P Cp Rubredoxin | monomer | 96.3 | 1×FE; | |||
| CLOSTRIDIUM PASTEURIANUM RUBREDOXIN G43A MUTANT | monomer | 98.15 | 1×FE; | |||
| CLOSTRIDIUM PASTEURIANUM RUBREDOXIN G10VG43A MUTANT | monomer | 96.3 | 1×FE; | |||
| The human P2Y1 receptor in complex with BPTU | monomer | 100.0 | 1×BUR; 1×CLR; 3×Y01; 8×OLC; 1×1PE; 1×ZN; | |||
| Crystal structure of human apo-Frizzled4 receptor | monomer | 100 | 1×ZN; 4×OLC; 5×OLA; 3×SO4; 4×UNX; | |||
| Crystal structure of the human thromboxane A2 receptor bound to ramatroban | monomer | 100 | 1×A8X; 1×ZN; 1×CLR; 2×OLC; 1×GOL; | |||
| Crystal structure of the human chemokine receptor CCR5 in complex with MIP-1a | monomer | 100.0 | 1×ZN; | |||
| The human P2Y1 receptor in complex with MRS2500 | monomer | 100 | 1×2ID; 1×ZN; | |||
| CRYSTAL STRUCTURE OF CCR2A IN COMPLEX WITH MK-0812 | monomer | 100.0 | 1×ZN; 11×OLA; 1×F7N; | |||
| Crystal structure of Apelin receptor in complex with small molecule | monomer | 100 | 1×ZN; 1×8EH; 1×OLC; | |||
| Crystal Structure of the CCR5 Chemokine Receptor | monomer | 100 | 1×MRV; 1×ZN; 6×OLC; | |||
| The Crystal structure of Human Chemokine Receptor CCR5 in complex with compound 34 | monomer | 100 | 1×ZN; 1×OLC; 1×A4X; | |||
| The Crystal structure of Human Chemokine Receptor CCR5 in complex with compound 21 | monomer | 100 | 1×ZN; 1×NO3; 1×A4R; | |||
| Crystal structure of the human thromboxane A2 receptor bound to daltroban | monomer | 100 | 1×A90; 1×ZN; 1×CLR; 1×GOL; | |||
| CRYSTAL STRUCTURE OF CCR2A IN COMPLEX WITH MK-0812 | monomer | 100 | 1×ZN; 1×F7N; | |||
| SOLUTION STRUCTURE OF REDUCED CLOSTRIDIUM PASTEURIANUM RUBREDOXIN, NMR, 20 STRUCTURES | monomer | 100 | 1×FE; | |||
| cadmium-substituted rubredoxin | monomer | 100 | 1×CD; | |||
| X-RAY CRYSTAL STRUCTURE OF REDUCED RUBREDOXIN | monomer | 100 | 1×FE2; | |||
| X-RAY CRYSTAL STRUCTURE OF OXIDIZED RUBREDOXIN | monomer | 100 | 1×FE; | |||
| Gallium-substituted rubredoxin | monomer | 100 | 1×GA; | |||
| mercury-substituted rubredoxin | monomer | 100 | 1×HG; | |||
| cobalt-substituted rubredoxin | monomer | 100 | 1×CO; | |||
| Crystal Structure of V44L Cp Rubredoxin | monomer | 98.11 | 1×FE; | |||
| nickel-substituted rubredoxin | monomer | 100 | 1×NI; | |||
| Crystal Structure of V44G Cp Rubredoxin | monomer | 98.11 | 1×FE; | |||
| Crystal structure of GPR52 ligand free form with rubredoxin fusion | monomer | 100 | 1×ZN; 11×OLC; 1×PEG; | |||
| XFEL crystal structure of human melatonin receptor MT2 (N86D) in complex with 2-phenylmelatonin | monomer | 100 | 1×JEY; 1×ZN; | |||
| XFEL crystal structure of human melatonin receptor MT2 (H208A) in complex with 2-phenylmelatonin | monomer | 100 | 1×JEY; 1×ZN; | |||
| XFEL crystal structure of human melatonin receptor MT2 in complex with ramelteon | monomer | 100 | 1×JEV; 1×ZN; | |||
| NMR and X-ray Analysis of Structural Additivity in Metal Binding Site-Swapped Hybrids of Rubredoxin | monomer | 86.54 | 1×ZN; 2×ACT; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4rxn.1.A | monomer | 0.83 | 1×FE; | 94.44 | ||